• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Large owner Genworth Holdings, Inc. sold $25,862,132 worth of shares (721,793 units at $35.83) (SEC Form 4)

    8/1/25 4:15:44 PM ET
    $ACT
    Specialty Insurers
    Finance
    Get the next $ACT alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Genworth Holdings, Inc.

    (Last) (First) (Middle)
    11011 WEST BROAD STREET

    (Street)
    GLEN ALLEN VA 23060

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Enact Holdings, Inc. [ ACT ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    07/31/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 07/31/2025 S(1) 721,793 D $35.8304(2) 119,521,762 D(3)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. The sale reported in this Form 4 was effected pursuant to a Share Repurchase Agreement between Enact Holdings, Inc. (the "Issuer") and Genworth Holdings, Inc. dated as of April 30, 2025 (the "Agreement"). A copy of the Agreement can be found as exhibit 10.1 to the Issuer's Form 10-Q for the quarterly period ended March 31, 2025, on the SEC's website at: https://www.sec.gov/Archives/edgar/data/1823529/000182352925000124/enact-genworthrepurchaseag.htm.
    2. Represents a price per share determined pursuant to the terms of the Agreement, based on a weighted average price paid by the Issuer for purchases from third-parties.
    3. Genworth Holdings, Inc. owns approximately 81% of the outstanding shares of common stock of the Issuer.
    /s/ Lisa J. Baldyga, Vice President and Treasurer on behalf of Genworth Holdings, Inc. 08/01/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ACT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACT

    DatePrice TargetRatingAnalyst
    5/5/2025$39.00Outperform → Mkt Perform
    Keefe Bruyette
    12/6/2023$29.00Neutral
    UBS
    11/13/2023$30.00Neutral → Buy
    BofA Securities
    5/9/2023$25.00 → $27.00Underperform → Neutral
    BofA Securities
    2/8/2023$25.00 → $26.50Mkt Perform → Outperform
    Keefe Bruyette
    1/9/2023$24.50Neutral → Underperform
    Credit Suisse
    9/6/2022$27.00Overweight → Neutral
    JP Morgan
    8/18/2022$25.00Neutral → Underperform
    BofA Securities
    More analyst ratings

    $ACT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Mcmullen James

    4 - Enact Holdings, Inc. (0001823529) (Issuer)

    4/3/26 8:43:10 AM ET
    $ACT
    Specialty Insurers
    Finance

    SEC Form 4 filed by Genworth Holdings, Inc.

    4 - Enact Holdings, Inc. (0001823529) (Issuer)

    4/1/26 4:20:03 PM ET
    $ACT
    Specialty Insurers
    Finance

    SEC Form 4 filed by Gould Brian

    4 - Enact Holdings, Inc. (0001823529) (Issuer)

    3/23/26 4:11:11 PM ET
    $ACT
    Specialty Insurers
    Finance

    $ACT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Enact to Host First Quarter 2026 Earnings Call May 6th

    RALEIGH, N.C., April 09, 2026 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact) announced it will issue its first quarter earnings release after the market closes on May 5, 2026. Enact will host a conference call to review first quarter 2026 financial results on May 6, 2026 at 8:00 a.m. (ET). Enact's earnings release, summary presentation and financial supplement will be available through the company's website, https://ir.enactmi.com, at the time of their release to the public. Participants interested in joining the call's live question and answer session are required to pre-register by clicking here to obtain a dial-in number and unique PIN. It is recommended to join at lea

    4/9/26 4:20:00 PM ET
    $ACT
    Specialty Insurers
    Finance

    Genworth Financial Schedules Earnings Conference Call for May 6

    Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing first quarter results after the market closes on May 5, 2026. A conference call will be held on May 6, 2026, at 9:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public. Genworth's conference call will be accessible via telephone and internet. The dial-in number for Genworth's May 6 conference call is 800-330-6710 or 213-279-1505 (outside the U.S.); conference ID #5100219. To participate in the call by we

    4/9/26 4:10:00 PM ET
    $ACT
    $GNW
    Specialty Insurers
    Finance
    Life Insurance

    Enact Releases 2025 Sustainability Report

    RALEIGH, N.C., March 25, 2026 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact) today announced the release of its 2025 Sustainability Report covering the calendar year 2025. The 2025 report builds on Enact's longstanding commitment to transparency and long-term value creation for stakeholders. It provides updated insights into the company's approach to sustainability, including ongoing efforts related to community impact, employee engagement and development, governance, and risk management. The report also reflects continued engagement with internal and external stakeholders to ensure Enact's sustainability priorities remain aligned with its business strategy. "On behalf of

    3/25/26 11:04:22 AM ET
    $ACT
    Specialty Insurers
    Finance

    $ACT
    SEC Filings

    View All

    SEC Form DEFA14A filed by Enact Holdings Inc.

    DEFA14A - Enact Holdings, Inc. (0001823529) (Filer)

    3/25/26 6:54:16 AM ET
    $ACT
    Specialty Insurers
    Finance

    SEC Form DEF 14A filed by Enact Holdings Inc.

    DEF 14A - Enact Holdings, Inc. (0001823529) (Filer)

    3/25/26 6:51:43 AM ET
    $ACT
    Specialty Insurers
    Finance

    SEC Form 10-K filed by Enact Holdings Inc.

    10-K - Enact Holdings, Inc. (0001823529) (Filer)

    2/27/26 7:27:08 AM ET
    $ACT
    Specialty Insurers
    Finance

    $ACT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Enact Holdings downgraded by Keefe Bruyette with a new price target

    Keefe Bruyette downgraded Enact Holdings from Outperform to Mkt Perform and set a new price target of $39.00

    5/5/25 8:29:05 AM ET
    $ACT
    Specialty Insurers
    Finance

    UBS initiated coverage on Enact Holdings with a new price target

    UBS initiated coverage of Enact Holdings with a rating of Neutral and set a new price target of $29.00

    12/6/23 7:20:51 AM ET
    $ACT
    Specialty Insurers
    Finance

    Enact Holdings upgraded by BofA Securities with a new price target

    BofA Securities upgraded Enact Holdings from Neutral to Buy and set a new price target of $30.00

    11/13/23 7:12:03 AM ET
    $ACT
    Specialty Insurers
    Finance

    $ACT
    Financials

    Live finance-specific insights

    View All

    Enact to Host First Quarter 2026 Earnings Call May 6th

    RALEIGH, N.C., April 09, 2026 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact) announced it will issue its first quarter earnings release after the market closes on May 5, 2026. Enact will host a conference call to review first quarter 2026 financial results on May 6, 2026 at 8:00 a.m. (ET). Enact's earnings release, summary presentation and financial supplement will be available through the company's website, https://ir.enactmi.com, at the time of their release to the public. Participants interested in joining the call's live question and answer session are required to pre-register by clicking here to obtain a dial-in number and unique PIN. It is recommended to join at lea

    4/9/26 4:20:00 PM ET
    $ACT
    Specialty Insurers
    Finance

    Genworth Financial Schedules Earnings Conference Call for May 6

    Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing first quarter results after the market closes on May 5, 2026. A conference call will be held on May 6, 2026, at 9:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public. Genworth's conference call will be accessible via telephone and internet. The dial-in number for Genworth's May 6 conference call is 800-330-6710 or 213-279-1505 (outside the U.S.); conference ID #5100219. To participate in the call by we

    4/9/26 4:10:00 PM ET
    $ACT
    $GNW
    Specialty Insurers
    Finance
    Life Insurance

    Genworth Financial Announces Fourth Quarter 2025 Results

    Strategic Highlights Executed $94M in share repurchases in the quarter; $245M in 2025 and $790M since program inception as of December 31, 2025 Delivered 925 matches with home care providers1 in the CareScout Quality Network in the quarter with over 95% home care coverage of the aged 65-plus census population in the United States Closed acquisition of Seniorly, Inc. for total cash consideration of $15M Care Assurance launched in October and was live in 39 states as of December 31, 2025 Continued progress on the LTC2 MYRAP3 with $100M of gross incremental premium approvals in the quarter; approximately $34.5B estimated net present value achieved since 2012 from IFAs4 Financ

    2/23/26 4:10:00 PM ET
    $ACT
    $GNW
    Specialty Insurers
    Finance
    Life Insurance

    $ACT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Enact Holdings Inc. (Amendment)

    SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)

    2/13/24 4:15:14 PM ET
    $ACT
    Specialty Insurers
    Finance

    SEC Form SC 13G/A filed by Enact Holdings Inc. (Amendment)

    SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)

    1/24/24 5:00:27 PM ET
    $ACT
    Specialty Insurers
    Finance

    SEC Form SC 13G/A filed by Enact Holdings Inc. (Amendment)

    SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)

    2/13/23 12:30:19 PM ET
    $ACT
    Specialty Insurers
    Finance

    $ACT
    Leadership Updates

    Live Leadership Updates

    View All

    Enact Holdings Set to Join S&P SmallCap 600

    NEW YORK, April 9, 2025 /PRNewswire/ -- Enact Holdings Inc. (NASD: ACT) will replace SolarWinds Corp. (NYSE:SWI) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, April 16. Turn/River Capital is acquiring SolarWinds in a deal expected to close soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector April 16, 2025 S&P SmallCap 600 Addition Enact Holdings ACT Financials April 16, 2025 S&P SmallCap 600 Deletion SolarWinds SWI Information Technology For more information about S&P Dow Jones Indices, please vi

    4/9/25 5:42:00 PM ET
    $ACT
    $SPGI
    $SWI
    Specialty Insurers
    Finance
    Finance: Consumer Services
    Computer Software: Prepackaged Software

    Enact Announces Changes to its Board of Directors

    RALEIGH, N.C., March 11, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact) today announced that it has appointed H. Elizabeth (Liz) Mitchell as an Independent Director to serve on Enact's Board of Directors, effective March 11, 2025. She has also been appointed as a member of the Audit Committee. In addition, the company announced that Anne G. Waleski has made the decision not to stand for re-election at the 2025 Annual Shareholder Meeting on May 14, 2025. As a result of these actions, Enact's Board will temporarily increase in size from eleven to twelve directors until the company's 2025 Annual Shareholder Meeting. Ms. Mitchell brings deep financial, industry and public

    3/11/25 4:15:00 PM ET
    $ACT
    Specialty Insurers
    Finance